On May 27, 2022 FIMM warmly welcomes EMBL Director General Edith Heard to Finland and celebrates the occasion with an afternoon minisymposium capturing the unique translational impact that FIMM, EMBL and their partners have made in transforming Nordic science towards an international research hub.
Please join us as we showcase the science and impact and look forward to future opportunities! No registration necessary. Join in Biomedicum Lecture Hall 1 or online via Zoom.
Zoom link:
https://helsinki.zoom.us/j/64298110752?pwd=NWpXQnZoN1ViS3hXOTN6cjZKUm92UT09
Passcode: 797638
Programme:
12.30 Opening words
Mark Daly, FIMM Director
12.35 EMBL’s new Programme and links with Finland
Edith Heard, EMBL Director General
12.55 The first decade of FIMM
Olli Kallioniemi, Director of SciLifeLab and Jaakko Kaprio, FIMM Research Director
13.10 FIMM at 15
Mark Daly, FIMM Director
13.20 Precision cancer research and FIMM
13.20 The FIMM – HUS journey towards precision hematology
Kimmo Porkka, Professor, Department of Medicine and Caroline Heckman, FIMM Research Director
13.35 iCAN: digital precision cancer medicine for discoveries and improved treatments
Tomi Mäkelä, iCAN Executive Officer
13.45 Reflections on FIMM: Kjetil Taskén, Head of Institute of Cancer Research, Oslo University Hospital
13.50 Human genomics for health and disease research and FIMM
13.50 FinnGen: a public-private partnership improving human health through genetic research
Aarno Palotie, FIMM Research Director, and Mark Daly, FIMM Director
14:05 Reflections on FIMM: Heiko Runz, Biogen Senior Medical Director, Head of Human Genetics
14.10 Genetic risk of disease and translation opportunities
Samuli Ripatti, FIMM Vice Director
14.20 Digital diagnostics for precision medicine and FIMM
14.20 Digital diagnostics in the global setting
Nina Linder, FIMM Senior Researcher and Harrison Kaingu, Kinondo Kwetu Medical Center, Kenya
14.35 Perspectives on the importance of EMBL and FIMM in Finland
14.35 On partnership with FIMM on virus sequencing: Carita Savolainen-Kopra, Chief Specialist, Head of Microbiology Unit, Finnish Institute of Health and Welfare
14.40 Marja Makarow, President of Academia Europaea
14.50 Anita Lehikoinen, Permanent Secretary, Ministry of Education and Culture
14.55 Sirpa Nuotio, EMBL Council Delegate, Senior Science Adviser, Academy of Finland
15.00 Kai Simons, Emeritus Director Max Planck Institute for Molecular Cell Biology and Genetics, CEO Lipotype GmbH
15.10 Jouni Hirvonen, University of Helsinki Vice Rector for Research (TBC)
15.15 FIMM Visiting Professor Jonathan Knowles
15.25 Closing words by Mark Daly, FIMM Director
15.30 Reception
